Description
The dibenzocyclooctyne (DBCO) in 4-Arm PEG-DBCO reacts with molecules containing azide groups (N3) in a Copper-free Click Chemistry. DBCO has very high reaction selectivity toward azide, enabling its use in modifying biomolecules including peptide, protein, enzyme, live cells, whole organisms etc. At physiological temperature and pH, DBCO does not react with amine or hydroxyl. DBCO also reacts with the azide group much faster than with free thiol groups. DBCO is also known as ADIBO (= Azadibenzocyclooctyne) or DIBAC (= Dibenzoazacyclooctyne), is one type of strained cyclooctyne.
Properties
Molecular weight: 4-Arm PEG MW refers to the MW of the entire PEG molecule. The MW of each arm is 1/4 of the MW indicated in the product name. MW of PEG was measured by MALDI-MS or GPC. PDI (polydispersity index) of our 4-Arm PEG is 1.02-1.05 with very narrow MW distribution. The number of repeating ethylene oxide units (CH2CH2O) or the degree of polymerization is calculated dividing the PEG MW by 44 (44 is the molecular mass of one repeating unit).
Solubility: Soluble in water and aqueous buffer, chloroform, methylene chloride, DMF, DMSO, and less soluble in alcohol, toluene. Not soluble in ether.
Density: PEG density is approximately 1.125 g/mL.
Physical form: PEG products generally appear as white or off-white powder, and for very low MW 4-Arm PEG such as MW 2k, it may appear as wax-like, semi-solid material due to the low MW and the type of functional groups.
Storage condition: PEG product shall be stored in the original form as received in a freezer at -20C or lower for long term storage. Stock solution of PEG reagents that do not contain oxygen or moisture sensitive functional groups may be temporarily stored in a refrigerator or ambient temperature for multiple days. Stock solution should avoid repeated freeze-and-thaw cycles. See Documents section for detailed storage and handling conditions.
References
1. Main-Chain Liquid Crystalline Hydrogels that Support 3D Stem Cell Culture, Biomacromolecules 2020, doi: 10.1021/acs.biomac.0c00316
2. The Design of Vaccines Based on the Shielding of Antigenic Site of a Respiratory Syncytial Virus Fusion Protein Immunogen, Adv. Healthcare Mater, 2020, doi: 10.1002/adhm.202000714
Click here to view an expanded list of thousands of publications citing Creative PEGWorks products.
Cart : 0
Account
